Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baijieyi for chemotherapy-induced thrombocytopenia
CTR20132305Phase 4Active
- Sponsor
- Shandong Ahua Biological Pharmaceutical
- Start
- Jan 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of oprelvekin in chemotherapy-induced thrombocytopenia (CIT), sponsored by Shandong Ahua Biological Pharmaceutical. Started Jan 2014; status: active.
02
Drugs
oprelvekin
03
Conditions
chemotherapy-induced thrombocytopenia (CIT)
Beyond the preview
Go deeper on CTR20132305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132305.